|
시장보고서
상품코드
1876452
세계의 안구건조증 치료 장치 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년) - 유형별, 원인별, 용도별, 최종 사용자별, 지역별Dry Eye Disease Treatment Devices Market - Global Dry Eye Disease Treatment Devices Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Type, By Cause, By Application,By End Users, By Geographic Coverage and By Company) |
||||||
세계의 안구건조증 치료 장치 시장 규모는 연령층이나 지역을 불문하고 안구건조증의 부담이 계속 증가하는 가운데 견조한 성장을 보이고 있습니다. 스크린 의존도 증가, 라이프 스타일의 변화, 눈 건강에 대한 의식이 증가함에 따라 고급 치료 기술에 대한 수요가 빠르게 가속화되고 있습니다. 본 시장은 2025년에 2억 6,000만 달러로 평가되고, 2032년까지 4억 3,000만 달러에 이를 것으로 예측되고 있으며, CAGR은 7.5%를 나타낼 전망입니다. 기존의 치료 접근 방식에서 장치 기반 치료 관리로의 전환은 업계의 장기 성장 전망을 강화하고 있습니다.
시장 인사이트
안구건조증(DED)은 삶의 질과 시각 기능에 영향을 미치는 세계에서 가장 일반적으로 진단되는 안과 질환 중 하나로 발전했습니다. 임상가가 보다 효과적인 치료법을 모색하는 동안, 장치 기반 치료법은 비침습성, 신속한 증상 완화 효과, 그리고 단순한 대증 요법이 아닌 근본적인 선 기능 장애를 해결할 수 있다는 점에서 주목을 받고 있습니다.
열 펄스 치료, 표적 광선 치료, 자동 마이 보임 선 치료, 가정 유지 관리 장치 등의 기술적 진보가 치료의 연속성을 재구성하고 있습니다. 계발 캠페인 증가와 환자의 프리미엄 치료 솔루션 도입에 대한 의욕 증가가 시장 확대를 더욱 뒷받침하고 있습니다. 제조업체 각사는 증가하는 임상 현장 및 재택에서 수요에 응하기 위해, 인체공학에 근거한 설계, 휴대성, 치료 효율의 향상에 주력하고 있습니다.
시장 성장 촉진요인
디지털 기기의 사용 급증, 특히 젊은층에서의 이용 확대는 안구건조증 증례 증가의 주요인 중 하나가 되고 있습니다. 컴퓨터 중심의 직장 환경 증가, 스마트폰 의존도의 향상, 장시간의 화면 노출이 순간 이상이나 눈물층 불안정화를 초래하고 있습니다. 노화와 관련된 변화, 환경 요인, 콘택트렌즈 사용, 수술 후 건조, 약물 관련 증상과 함께이 질병의 유병률은 계속 증가하고 있습니다.
혁신적인 기술이 주요 추진력이 되고 있으며, 현대의 의료기기는 마이 봄선의 폐색이나 눈물 배출 경로에 대해 표적을 좁힌 치료 효과를 제공합니다. 진단 능력의 향상에 의해 조기 발견이 가능해져, 치료의 기회가 확대되고 있습니다. 의료비 증가, 환자 의식 향상, 통합 기술 솔루션에 대한 임상 현장 선호도 증가는 지속적인 수요를 지원합니다. 규제 당국의 승인을 받기 쉽고 제품의 가용성이 광범위하다는 것도 시장 확대에 기여하고 있습니다.
비즈니스 기회
세계 시장은 임상 현장과 재택 관리 모두에서 큰 기회를 제공합니다. 특히 선진국 시장에서는 환자가 통원 횟수를 최소화하면서 장기적인 쾌적성을 요구하는 경향이 강해지고 있어 일상적인 유지보수용으로 설계된 콤팩트하고 사용하기 쉬운 기기의 인기가 높아지고 있습니다. 온열·진동·기계적 자극을 조합한 비용 효율적인 하이브리드 치료 시스템에 주력하는 기업은 큰 주목을 끌 것으로 예측됩니다.
원격 안과 진료, 인공지능 구동 안과 진단, 스마트 모니터링 플랫폼과의 통합은 미래 성장을 위한 강력한 잠재력을 지니고 있습니다. 제조업체와 주요 안과 체인과의 제휴는 유통 효율을 향상시켜 기업의 브랜드 인지도 향상에 기여하고 있습니다. 또한, 의료 접근성 향상으로 안과 장비의 도입이 진행되는 신흥 시장으로의 침투 확대는 유망한 성장 경로를 제공합니다.
지역별 분석
북미는 안구건조증에 대한 인지도의 광범위한 침투, 첨단치료 장치의 높은 채용률, 디지털 안정피로 증가로 세계의 안구건조증 치료 장치 시장에서 주요 점유율을 차지하고 있습니다. 이 지역은 안과 클리닉의 강력한 네트워크, 높은 구매력, 지속적인 혁신의 혜택을 누리고 있습니다.
유럽에서는 고령화 인구 증가, 전문 의료에 대한 접근 확대, 비침습적 치료법의 선호도 상승을 배경으로 꾸준한 성장이 계속되고 있습니다. 선진 의료기기에 대한 규제면의 지원과 고품질 안과 의료 기술에 대한 강한 수요가 이 지역 시장 확대에 기여하고 있습니다.
아시아태평양은 예측 기간에 가장 성장이 빠른 지역 시장으로 상승할 것으로 예측됩니다. 급속한 도시화, 장시간의 화면 노출, 콘택트렌즈 사용률의 높이가 안구건조증 유병률 상승의 주요 요인입니다. 중국, 인도, 일본, 한국 등의 나라에서는 안과 의료 인프라가 급속히 확충되고 있어 기기 제조업체에 있어서 큰 기회가 탄생하고 있습니다.
라틴아메리카 및 중동 및 아프리카에서는 의료 액세스 개선, 민간 병원 네트워크 확대, 눈 건강 및 예방 의료 기술에 대한 의식 향상을 바탕으로 성장 가능성이 높아지고 있습니다.
주요 기업
- Alcon Vision LLC
- Johnson and Johnson Services Inc
- AbbVie Inc.
- Lumenis Be Ltd
- ESW - Vision
- MiBo Medical Group
- Sight Sciences
- Eyedetec Medical Inc.
- BlephEx
- NuSight Medicals- NuLids LLC
- 기타
세계의 안구건조증 치료 장치 시장 세분화
유형별
- 마이봄샘 막힘 제거 장치
- 점액관 폐쇄 장치
- 통증 완화 장치
- 기타
원인별
- 특발성
- 희귀 질환
- 수술
- 약물 복용 관련
- 디지털 노출
- 노화 관련
용도별
- 수분 부족형
- 증발형
최종 사용자별
- 병원
- 안과 센터
- 외래 수술 센터(ASC)
- 기타
지역별
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
목차
제1장 주요 요약
제2장 시장 개요
- 시장 정의와 세분화
- 시장 역학
- 밸류체인 분석
- COVID-19의 영향 분석
- Porter's Five Forces 분석
- 러시아·우크라이나 분쟁의 영향
- PESTLE 분석
- 규제 분석
- 가격 동향 분석
제3장 세계의 안구건조증 치료 장치 시장 전망(2019-2032년)
- 세계의 안구건조증 치료 장치 시장 전망, 유형별, 금액(100만 달러, 2019-2032년)
- 마이봄샘 막힘 제거 장치
- 점액관 폐쇄 장치
- 통증 완화 장치
- 기타
- 세계의 안구건조증 치료 장치 시장 전망, 원인별, 금액(100만 달러, 2019-2032년)
- 특발성
- 희귀 질환
- 수술
- 약물 복용 관련
- 디지털 노출
- 노화 관련
- 세계의 안구건조증 치료 장치 시장 전망, 용도별, 금액(100만 달러, 2019-2032년)
- 수분 부족형
- 증발형
- 세계의 안구건조증 치료 장치 시장 전망, 최종 사용자별, 금액(100만 달러, 2019-2032년)
- 병원
- 안과 센터
- 외래 수술 센터(ASC)
- 기타
- 세계의 안구건조증 치료 장치 시장 전망, 지역별, 금액(100만 달러, 2019-2032년)
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
제4장 북미의 안구건조증 치료 장치 시장 전망(2019-2032년)
제5장 유럽의 안구건조증 치료 장치 시장 전망(2019-2032년)
제6장 아시아태평양의 안구건조증 치료 장치 시장 전망(2019-2032년)
제7장 라틴아메리카의 안구건조증 치료 장치 시장 전망(2019-2032년)
제8장 중동 및 아프리카의 안구건조증 치료 장치 시장 전망(2019-2032년)
제9장 경쟁 구도
- 기업 대 부문 히트맵
- 기업의 시장 점유율 분석(2024년)
- 경쟁 대시보드
- 기업 프로파일
- Alcon Vision LLC
- Johnson and Johnson Services Inc
- AbbVie Inc.
- Lumenis Be Ltd
- ESW - Vision
- MiBo Medical Group
- Sight Sciences
- Eyedetec Medical Inc.
- BlephEx
- NuSight Medicals- NuLids LLC
제10장 부록
KTHThe global Dry Eye Disease Treatment Devices Market is witnessing robust growth as the burden of dry eye continues to rise across age groups and geographies. With increasing screen dependency, lifestyle transitions, and expanding awareness of ocular health, demand for advanced treatment technologies is accelerating rapidly. The market is valued at USD 260 million in 2025 and is projected to reach USD 430 million by 2032, registering a CAGR of 7.5%. The shift from traditional treatment approaches to device-based therapeutic care is strengthening the industry's long-term growth outlook.
Market Insights
Dry Eye Disease (DED) has evolved into one of the most commonly diagnosed ophthalmic conditions globally, impacting quality of life and visual performance. As clinicians seek more effective interventions, device-based therapies are gaining momentum due to their non-invasive nature, faster relief outcomes, and ability to address underlying gland dysfunction rather than only providing symptomatic improvement.
Technological advancements such as thermal pulsation, targeted light-based therapy, automated meibomian gland treatment, and at-home maintenance devices continue to reshape the care continuum. Increasing awareness campaigns and growing willingness among patients to adopt premium therapeutic solutions are further supporting market expansion. Manufacturers are increasingly focusing on ergonomic design, portability, and improved treatment efficiency to meet rising clinical and at-home demand.
Market Drivers
A surge in digital device usage, particularly among younger populations, has become one of the most significant contributors to the growing incidence of dry eye. The rise in computer-centric work environments, increased smartphone dependence, and prolonged screen exposure contribute to blinking abnormalities and tear film instability. Combined with age-related changes, environmental factors, contact lens use, post-operative dryness, and medication-associated symptoms, the prevalence of the disease continues to escalate.
Innovation serves as a central driver, with modern devices offering targeted therapeutic action on meibomian gland obstructions and tear drainage pathways. Improved diagnostic capabilities are enabling early detection, thus expanding treatment opportunities. Growing healthcare expenditure, rising patient awareness, and greater clinical preference for integrated technology-based solutions support sustained demand. Favorable regulatory approvals and broader product availability further contribute to market expansion.
Business Opportunity
The global market offers considerable opportunities across both clinical and home-care settings. Compact and user-friendly devices designed for daily maintenance are becoming increasingly popular, especially in developed markets where patients prefer long-term comfort solutions with minimal clinic visits. Companies focusing on cost-effective, hybrid therapy systems that combine heat, vibration, and mechanical stimulation are expected to gain substantial traction.
Integration with tele-ophthalmology, AI-driven eye diagnostics, and smart-monitoring platforms presents strong potential for future growth. Partnerships between manufacturers and large eye care chains are improving distribution efficiency and helping companies enhance brand visibility. Additionally, expanding penetration into emerging markets, where rising healthcare access is boosting ophthalmic device adoption, offers promising growth avenues.
Region Analysis
North America holds a major share in the global Dry Eye Disease Treatment Devices Market due to widespread awareness of dry eye conditions, high adoption of advanced therapeutic devices, and increased prevalence of digital eye strain. The region benefits from a strong network of eye care clinics, high purchasing power, and ongoing technological innovation.
Europe continues to show steady growth driven by a rising elderly population, increased access to specialty care, and rising preference for non-invasive therapeutic options. Regulatory support for advanced medical devices and strong demand for premium eye care technologies contribute to the region's expanding market presence.
Asia Pacific is expected to emerge as the fastest-growing regional market over the forecast period. Rapid urbanization, extensive screen exposure, and high rates of contact lens use are major contributors to rising dry eye prevalence. Countries such as China, India, Japan, and South Korea are witnessing rapid expansion in eye care infrastructure, creating significant opportunities for device manufacturers.
Latin America and the Middle East & Africa show growing potential supported by improving healthcare access, expanding private hospital networks, and increasing awareness about eye health and preventive care technologies.
Key Players
- Alcon Vision LLC
- Johnson and Johnson Services Inc
- AbbVie Inc.
- Lumenis Be Ltd
- ESW - Vision
- MiBo Medical Group
- Sight Sciences
- Eyedetec Medical Inc.
- BlephEx
- NuSight Medicals- NuLids LLC
- Others
Global Dry Eye Disease Treatment Devices Market Segmentation
By Type
- Meibomian Gland Unclogging Devices
- Punctual Occlusion Devices
- Pain-Reliving Devices
- Others
By Cause
- Idiopathic
- Rare Diseases
- Surgery
- Drug Intake Associated
- Digital Exposure
- Age-Related
By Application
- Aqueous Deficient
- Evaporative
By End Users
- Hospitals
- Eye Care Centers
- Ambulatory Surgical Centers
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Dry Eye Disease Treatment Devices Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2025
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Fiver Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2032
- 2.9.2. Price Impact Factors
3. Global Dry Eye Disease Treatment Devices Market Outlook, 2019-2032
- 3.1. Global Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
- 3.1.1. Meibomian Gland Unclogging Devices
- 3.1.2. Punctual Occlusion Devices
- 3.1.3. Pain-Reliving Devices
- 3.1.4. Others
- 3.2. Global Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
- 3.2.1. Idiopathic
- 3.2.2. Rare Diseases
- 3.2.3. Surgery
- 3.2.4. Drug Intake Associated
- 3.2.5. Digital Exposure
- 3.2.6. Age-Related
- 3.3. Global Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
- 3.3.1. Aqueous Deficient
- 3.3.2. Evaporative
- 3.4. Global Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
- 3.4.1. Hospitals
- 3.4.2. Eye Care Centers
- 3.4.3. Ambulatory Surgical Centers
- 3.4.4. Others
- 3.5. Global Dry Eye Disease Treatment Devices Market Outlook, by Region, Value (US$ Mn), 2019-2032
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa
4. North America Dry Eye Disease Treatment Devices Market Outlook, 2019-2032
- 4.1. North America Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
- 4.1.1. Meibomian Gland Unclogging Devices
- 4.1.2. Punctual Occlusion Devices
- 4.1.3. Pain-Reliving Devices
- 4.1.4. Others
- 4.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
- 4.2.1. Idiopathic
- 4.2.2. Rare Diseases
- 4.2.3. Surgery
- 4.2.4. Drug Intake Associated
- 4.2.5. Digital Exposure
- 4.2.6. Age-Related
- 4.3. North America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
- 4.3.1. Aqueous Deficient
- 4.3.2. Evaporative
- 4.4. North America Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
- 4.4.1. Hospitals
- 4.4.2. Eye Care Centers
- 4.4.3. Ambulatory Surgical Centers
- 4.4.4. Others
- 4.5. North America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
- 4.5.1. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 4.5.2. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 4.5.3. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 4.5.4. U.S. Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 4.5.5. Canada Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 4.5.6. Canada Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 4.5.7. Canada Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 4.5.8. Canada Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Dry Eye Disease Treatment Devices Market Outlook, 2019-2032
- 5.1. Europe Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
- 5.1.1. Meibomian Gland Unclogging Devices
- 5.1.2. Punctual Occlusion Devices
- 5.1.3. Pain-Reliving Devices
- 5.1.4. Others
- 5.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
- 5.2.1. Idiopathic
- 5.2.2. Rare Diseases
- 5.2.3. Surgery
- 5.2.4. Drug Intake Associated
- 5.2.5. Digital Exposure
- 5.2.6. Age-Related
- 5.3. Europe Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
- 5.3.1. Aqueous Deficient
- 5.3.2. Evaporative
- 5.4. Europe Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
- 5.4.1. Hospitals
- 5.4.2. Eye Care Centers
- 5.4.3. Ambulatory Surgical Centers
- 5.4.4. Others
- 5.5. Europe Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
- 5.5.1. Germany Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 5.5.2. Germany Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 5.5.3. Germany Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 5.5.4. Germany Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 5.5.5. Italy Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 5.5.6. Italy Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 5.5.7. Italy Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 5.5.8. Italy Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 5.5.9. France Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 5.5.10. France Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 5.5.11. France Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 5.5.12. France Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 5.5.13. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 5.5.14. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 5.5.15. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 5.5.16. U.K. Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 5.5.17. Spain Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 5.5.18. Spain Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 5.5.19. Spain Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 5.5.20. Spain Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 5.5.21. Russia Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 5.5.22. Russia Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 5.5.23. Russia Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 5.5.24. Russia Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 5.5.25. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 5.5.26. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 5.5.27. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 5.5.28. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, 2019-2032
- 6.1. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
- 6.1.1. Meibomian Gland Unclogging Devices
- 6.1.2. Punctual Occlusion Devices
- 6.1.3. Pain-Reliving Devices
- 6.1.4. Others
- 6.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
- 6.2.1. Idiopathic
- 6.2.2. Rare Diseases
- 6.2.3. Surgery
- 6.2.4. Drug Intake Associated
- 6.2.5. Digital Exposure
- 6.2.6. Age-Related
- 6.3. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
- 6.3.1. Aqueous Deficient
- 6.3.2. Evaporative
- 6.4. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
- 6.4.1. Hospitals
- 6.4.2. Eye Care Centers
- 6.4.3. Ambulatory Surgical Centers
- 6.4.4. Others
- 6.5. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
- 6.5.1. China Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 6.5.2. China Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 6.5.3. China Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 6.5.4. China Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 6.5.5. Japan Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 6.5.6. Japan Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 6.5.7. Japan Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 6.5.8. Japan Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 6.5.9. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 6.5.10. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 6.5.11. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 6.5.12. South Korea Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 6.5.13. India Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 6.5.14. India Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 6.5.15. India Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 6.5.16. India Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 6.5.17. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 6.5.18. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 6.5.19. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 6.5.20. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 6.5.21. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 6.5.22. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 6.5.23. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 6.5.24. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Dry Eye Disease Treatment Devices Market Outlook, 2019-2032
- 7.1. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
- 7.1.1. Meibomian Gland Unclogging Devices
- 7.1.2. Punctual Occlusion Devices
- 7.1.3. Pain-Reliving Devices
- 7.1.4. Others
- 7.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
- 7.2.1. Idiopathic
- 7.2.2. Rare Diseases
- 7.2.3. Surgery
- 7.2.4. Drug Intake Associated
- 7.2.5. Digital Exposure
- 7.2.6. Age-Related
- 7.3. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
- 7.3.1. Aqueous Deficient
- 7.3.2. Evaporative
- 7.4. Latin America Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
- 7.4.1. Hospitals
- 7.4.2. Eye Care Centers
- 7.4.3. Ambulatory Surgical Centers
- 7.4.4. Others
- 7.5. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
- 7.5.1. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 7.5.2. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 7.5.3. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 7.5.4. Brazil Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 7.5.5. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 7.5.6. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 7.5.7. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 7.5.8. Mexico Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 7.5.9. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 7.5.10. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 7.5.11. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 7.5.12. Argentina Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 7.5.13. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 7.5.14. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 7.5.15. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 7.5.16. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, 2019-2032
- 8.1. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
- 8.1.1. Meibomian Gland Unclogging Devices
- 8.1.2. Punctual Occlusion Devices
- 8.1.3. Pain-Reliving Devices
- 8.1.4. Others
- 8.2. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
- 8.2.1. Idiopathic
- 8.2.2. Rare Diseases
- 8.2.3. Surgery
- 8.2.4. Drug Intake Associated
- 8.2.5. Digital Exposure
- 8.2.6. Age-Related
- 8.3. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
- 8.3.1. Aqueous Deficient
- 8.3.2. Evaporative
- 8.4. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
- 8.4.1. Hospitals
- 8.4.2. Eye Care Centers
- 8.4.3. Ambulatory Surgical Centers
- 8.4.4. Others
- 8.5. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
- 8.5.1. GCC Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 8.5.2. GCC Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 8.5.3. GCC Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 8.5.4. GCC Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 8.5.5. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 8.5.6. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 8.5.7. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 8.5.8. South Africa Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 8.5.9. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 8.5.10. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 8.5.11. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 8.5.12. Egypt Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 8.5.13. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 8.5.14. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 8.5.15. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 8.5.16. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 8.5.17. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
- 8.5.18. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
- 8.5.19. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
- 8.5.20. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
- 8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2024
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Alcon Vision LLC
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Johnson and Johnson Services Inc
- 9.4.2.1. Company Overview
- 9.4.2.2. Product Portfolio
- 9.4.2.3. Financial Overview
- 9.4.2.4. Business Strategies and Developments
- 9.4.3. AbbVie Inc.
- 9.4.3.1. Company Overview
- 9.4.3.2. Product Portfolio
- 9.4.3.3. Financial Overview
- 9.4.3.4. Business Strategies and Developments
- 9.4.4. Lumenis Be Ltd
- 9.4.4.1. Company Overview
- 9.4.4.2. Product Portfolio
- 9.4.4.3. Financial Overview
- 9.4.4.4. Business Strategies and Developments
- 9.4.5. ESW - Vision
- 9.4.5.1. Company Overview
- 9.4.5.2. Product Portfolio
- 9.4.5.3. Financial Overview
- 9.4.5.4. Business Strategies and Developments
- 9.4.6. MiBo Medical Group
- 9.4.6.1. Company Overview
- 9.4.6.2. Product Portfolio
- 9.4.6.3. Financial Overview
- 9.4.6.4. Business Strategies and Developments
- 9.4.7. Sight Sciences
- 9.4.7.1. Company Overview
- 9.4.7.2. Product Portfolio
- 9.4.7.3. Financial Overview
- 9.4.7.4. Business Strategies and Developments
- 9.4.8. Eyedetec Medical Inc.
- 9.4.8.1. Company Overview
- 9.4.8.2. Product Portfolio
- 9.4.8.3. Financial Overview
- 9.4.8.4. Business Strategies and Developments
- 9.4.9. BlephEx
- 9.4.9.1. Company Overview
- 9.4.9.2. Product Portfolio
- 9.4.9.3. Financial Overview
- 9.4.9.4. Business Strategies and Developments
- 9.4.10. NuSight Medicals- NuLids LLC
- 9.4.10.1. Company Overview
- 9.4.10.2. Product Portfolio
- 9.4.10.3. Financial Overview
- 9.4.10.4. Business Strategies and Developments
- 9.4.1. Alcon Vision LLC
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
